Citadel Advisors »

Psyence Biomedical shares owned by Citadel Advisors

Quarter-by-quarter ownership of Psyence Biomedical (PBM) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Psyence Biomedical

Tip: Access up to 7 years of quarterly data

All positions including Psyence Biomedical held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Psyence Biomedical by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $17k 169k 0.10

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Psyence Biomedical

AdvisorShares Investments
Cantor Fitzgerald, L. P.
Citadel Advisors
Stonehage Fleming Financial Services Holdings
Jane Street
Hrt Financial
Morgan Stanley
Clear Street
Virtu Financial
Geode Capital Management
Jpmorgan Chase & Co

View all funds holding Psyence Biomedical